PSYCHIATRIC DISTURBANCES ASSOCIATED WITH GANCICLOVIR THERAPY

被引:10
作者
CHEN, JL
BROCAVICH, JM
LIN, AYF
机构
[1] LONG ISL UNIV,ARNOLD & MARIE SCHWARTZ COLL PHARM & HLTH SCI,BROOKLYN,NY 11201
[2] LONG ISL UNIV,BROOKLYN,NY 11201
[3] ST JOHNS UNIV,COLL PHARM & ALLIED HLTH PROFESS,JAMAICA,NY 11439
关键词
D O I
10.1177/106002809202600210
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To report a case of possible ganciclovir-induced psychiatric disturbances. CASE SUMMARY: A patient with AIDS who had no known psychiatric history and mild renal dysfunction experienced exacerbation of cytomegalovirus retinitis and was treated with ganciclovir 5 mg/kg iv q12h. The patient complained of nightmares and developed visual hallucinations and severe agitation on day 15 of ganciclovir therapy. The problems resolved after haloperidol administration and ganciclovir withdrawal and reappeared when the same regimen was reinstituted. However, the patient was able to tolerate the maintenance dose of ganciclovir at 5 mg/kg/d along with haloperidol later without further episodes of visual hallucinations. DISCUSSION: Case reports in the literature on ganciclovir- or its analog, acyclovir-, induced psychiatric disturbances were reviewed and compared. The potential relationship between ganciclovir accumulation in patients with renal insufficiency and the observed central nervous system problems in our patient was postulated. CONCLUSIONS: It is likely that ganciclovir accumulation contributed to the acute psychotic episodes observed in our patient. Adjusting ganciclovir dosage based on the patient's renal function is probably the only approach required to prevent or reduce the incidence of these episodes.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 25 条
[1]  
BATAILLE P, 1985, LANCET, V1, P724
[2]  
BLAZER DG, 1976, DIS NERV SYST, V37, P663
[3]  
BUHLES WC, 1988, REV INFECT DIS, V10, pS495
[4]   9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
CHACHOUA, A ;
DIETERICH, D ;
KRASINSKI, K ;
GREENE, J ;
LAUBENSTEIN, L ;
WERNZ, J ;
BUHLES, W ;
KORETZ, S .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :133-137
[5]   UNIQUE SPECTRUM OF ACTIVITY OF 9-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]-GUANINE AGAINST HERPESVIRUSES INVITRO AND ITS MODE OF ACTION AGAINST HERPES-SIMPLEX VIRUS TYPE-1 [J].
CHENG, YC ;
HUANG, ES ;
LIN, JC ;
MAR, EC ;
PAGANO, JS ;
DUTSCHMAN, GE ;
GRILL, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09) :2767-2770
[6]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[7]   SEVERE BUT REVERSIBLE NEUROTOXICITY FROM ACYCLOVIR [J].
COHEN, SMZ ;
MINKOVE, JA ;
ZEBLEY, JW ;
MULHOLLAND, JH .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (06) :920-920
[8]  
DAVIS CL, 1990, NEW ENGL J MED, V322, P933
[9]   EXCESSIVE SERUM CONCENTRATIONS OF ACYCLOVIR AND NEUROTOXICITY [J].
FELDMAN, S ;
RODMAN, J ;
GREGORY, B .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (02) :385-388
[10]   9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE - A SELECTIVE INHIBITOR OF HERPES GROUP VIRUS-REPLICATION [J].
FIELD, AK ;
DAVIES, ME ;
DEWITT, C ;
PERRY, HC ;
LIOU, R ;
GERMERSHAUSEN, J ;
KARKAS, JD ;
ASHTON, WT ;
JOHNSTON, DBR ;
TOLMAN, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (13) :4139-4143